Reuters Health Report

Click to View in Browser 05/9/2014 Pfizer signs rare diseases deal with UK universities LONDON (Reuters) - U.S. drugmaker Pfizer, battling to buy British rival AstraZeneca, has struck a deal with leading British universities to hunt for new medicines to treat rare diseases. China adjusts pricing policy for cheaper drugs SHANGHAI (Reuters) - China has adjusted its policy on pricing cheaper drugs sold in the country, allowing drugmakers more leeway in deciding how much to charge for their treatments in the face of rising costs. Fruits and vegetables linked to stroke prevention NEW YORK (Reuters Health) - Eating more fruits and vegetables may reduce stroke risk by almost a third, according to a fresh look at recent evidence. U.S. FDA approves Merck blood clot preventer (Reuters) - U.S. health regulators on Thursday approved a blood clot preventer developed by Merck & Co for use by patients who have had a heart attack or who suffer from blockages in the arteries of the legs. Boston Scientific gets subpoena over defibrillators (Reuters) - Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Summer camps benefit children with special needs NEW YORK (Reuters Health) - As the weather warms and summer begins, dozens of camps across the nation will be catering to children and teens with special needs. Syphilis cases increase among U.S. gay and bisexual men: CDC ATLANTA (Reuters) - Syphilis, a sexually transmitted venereal disease, is rising among gay and bisexual men after being nearly eliminated in the United States more than a decade ago, according to a federal study released on Thursday. Vermont becomes first U.S. state to mandate GMO labeling (Reuters) - Vermont on Thursday became the first U.S. state to mandate labeling of foods made with genetically modified organisms as Governor Peter Shumlin signed a law that is widely expected to be challenged in court by some food and agriculture companies. Vivus's diet pill faces generic threat from Actavis (Reuters) - Vivus Inc said on Friday drugmaker Actavis Plc plans to market a generic version of Vivus's obesity drug Qsymia that was approved in July 2012. Scientists invent new letters for the alphabet of life NEW YORK (Reuters) - Scientists have taken the first steps toward writing the blueprint of life in an alphabet unknown to nature, they reported online in the journal Nature. Related Video Virtual universe revealed in unprecedented detail Cart-wheeling spider inspires robot for Mars The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend